Clinical Trial Update: Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing vinorelbine to gemcitabine plus vinorelbine in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Vinorelbine (Vinorelbine)
• Vinorelbine plus gemcitabine

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer, Neoplasm Metastasis | Phase 3 | Status: COMPLETED